BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Blue Cross Blue Shield of Massachusetts to Reimburse Small Bone Innovations, Inc.'s STAR(TM) Total Ankle Replacement


3/24/2011 9:54:54 AM

NEW YORK--(BUSINESS WIRE)-- Small Bone Innovations, Inc. (SBi) announced today that 38 of the 39 independent member companies of the BlueCross and BlueShield Association will cover SBi’s STAR™ Total Ankle Replacement system to benefit an estimated 98.5 million insured in 49 states.

SBi is an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint replacement (arthroplasty) and post-traumatic reconstruction of the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes, foot and ankle.

According to SBi, more than 90 percent of the approximately 175 million members of commercial insurance plans in the U.S. now have access to the STAR ankle replacement surgery, when deemed clinically appropriate by experienced surgeons.

“The STAR ankle is the first and only total ankle replacement system to have performed successfully in the FDA’s rigorous pre-market approval (PMA) process,” said James A. Nunley II, MD1, Chief of Orthopaedic Surgery at Duke University Medical Center in Durham, NC. “The compelling clinical data from the prospective, multi-center U.S. Investigational Device Exemption (IDE) STAR Ankle clinical trial, initiated in 2000, has been instrumental in the current stream of favorable coverage decisions by insurers as well as independent non-profit health care institutions.” Dr. Nunley is a clinical investigator in the STAR clinical trials who has assisted in SBi’s effort to benefit patients by changes in reimbursement policies.

“The STAR ankle is the only total ankle replacement indicated for use as a ‘non-cemented’ implant to replace painful ankle joints affected by osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis. In the IDE clinical trials, the STAR ankle was deemed superior in efficacy and comparable in safety when compared to fusion, for treating ankle arthritis,” Dr. Nunley added.

1 Dr. Nunley is paid consultant to SBi - providing education services.

Click here for access to sites of the 38 regional BlueCross BlueShield regional sites.

About Small Bone Innovations, Inc

Small Bone Innovations, Inc. (SBi), founded in 2004 by Viscogliosi Bros., LLC, the New York-based merchant banking firm specializing in orthopedics. SBi is the first company to focus purely on treating disease and trauma in the small bones & joints through a broad, clinically proven portfolio of products.

For a notice on Forward Looking Statements and more information about SBi, please visit:

http://www.totalsmallbone.com/us/press.php4.

Contacts

Small Bone Innovations, Inc. Varun Gandhi, 212-583-0370 ext. 2126 vgandhi@totalsmallbone.com

Source: Small Bone Innovations, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES